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Tamm Horsfall protein binds to a single class of carbohydrate specific
receptors on human neutrophils. Several studies have implicated urinary
Tamm Horsfall protein (THP) in the aetiology of tubulointerstitial
inflammation. Previous research has demonstrated that particulate THP
will initiate inflammatory activation of human polymorphonuclear leu-
kocytes (PMN) through a trypsin sensitive mechanism. The present
study describes the binding of '251-monomeric THP to human PMN at
4°C and demonstrates that radiolabeled THP binds to PMN in a
saturable, reversible and time dependent manner. The addition of 400 to
600 ng '251-THP/2 x 106 PMN was sufficient to achieve saturable
binding. Scatchard analysis of binding data yielded linear plots suggest-
ing a single class of receptors with a mean density of 26218/cell and a
dissociation constant (Ku) of 4.2 x lO M. Binding reached steady
state by 15 minutes and could be rapidly displaced by the addition of an
excess of unlabeled THP. The K0 calculated from experimentally
derived kinetic rate constants (k1 and k2) was of a similar order of
magnitude (0.9 x l0— M) to that generated from Scatchard plots. In
addition '251-THP bound specifically to PMN plasma membranes im-
mobilized on nitroceilulose filters, a process which could be inhibited
by unlabeled monomeric THP. Chemical modification of unlabeled
THP abolished its capacity to inhibit binding. Specific inhibition studies
showed that N-acetylneuraminic (sialic) acid dose dependently dis-
placed the binding of '251-THP to immobilized PMN membranes at
concentrations up to 100 mrt. These results indicate that the reported
activation of human PMN by THP is mediated through a single class of
sialic acid-specific cell surface receptors.
response to THP may in part be responsible for the inflamma-
tion and fibrosis associated with TIN.
Recent in vitro studies [11, 12] in this laboratory have further
highlighted the pro-inflammatory potential of the glycoprotein
by demonstrating a significant ability for aggregated (particu-
late) THP to activate human neutrophils (PMN) and monocytes
(MNC). Activation of these cells was assessed by the release of
intracellular enzymes, arachidonic acid metabolism and gener-
ation of reactive oxygen metabolites.
In addition, preliminary data indicated that the response of
PMN to THP was sensitive to low concentrations of trypsin,
suggesting that the major recognition mechanism for THP on
PMN was a cell surface protein. The present study uses THP in
its soluble (monomeric) form [3] to further examine the PMN/
THP interaction. A simple binding isotherm is employed to
characterize cell surface recognition sites in terms of number
and binding affinity while the specificity of the THPIPMN
interaction is investigated using a solid phase binding assay.
Methods
Preparation of human neutrophils
Tamm Horsfall protein (THP), a renal glycoprotein synthe-
sized exclusively by the epithelial cells of the thick ascending
limb (TAL) and early distal tubule [1, 2] is found in both the
urine and serum of healthy individuals [3, 4]. The precise
physiological function of this glycoprotein is unknown, but it
has been suggested that THP is responsible for maintaining the
water impermeability of the thick ascending limb of the loop of
Henle [5]. In contrast a number of studies have also indicated a
pathological role for THP. Clinical and experimental models
have implicated the glycoprotein in the pathogenesis of tubu-
lointerstitial nephritis (TIN) [6—10]. In these studies interstitial
deposits of THP were associated with pleomorphic inflamma-
tory cell infiltrates, leading to the suggestion that an immune
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Human neutrophils (PMN) were isolated from citrated pe-
ripheral blood by dextran sedimentation and Ficoll-Pague den-
sity gradient centrifugation as previously described [13]. This
method yielded a cell prepartion of >98% PMN as determined
by their morphology.
Tamm Horsfall protein
Polymeric Tamm Horsfall protein (THP), purified from
pooled human urine by repeated salt precipitation [14] was
disaggregated with 8 M urea and chromatographed over
Sepharose 4B as previously described [3] to yield a pure
preparation of monomeric THP. This material ran as a single
band of molecular mass 90 kDa on SDS-polyacrylamide gels
under non-reducing conditions.
Monomeric THP was iodinated using N-chloro benzene
sulphonamide derivatized beads (lodobeads, Life Science Lab-
oratories Ltd., Luton, UK) according to manufacturers instruc-
tions. Labeling of 50 g of THP with 0.5 mCi of Na[1251] for 15
minutes at room temperature resulted in a typical specific
activity of between 1 and 3 Ci/sg protein.
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Chemical modfIcation of monomeric THF
(i) Reduction and ailcylation. Monomeric THP (1 mg) was
dissolved in 1 ml distilled water and dialyzed overnight against
100 ml of 50 mr's Tris-HCI, pH 8.0 containing 0.01 M dithiothre-
itol. Jodoacetamide was added to the solution of reduced THP
at a final concentration of 10 m and the mixture left in the dark
for two hours.
(ii) Periodate oxidation. Monomeric THP (1 mg) was dis-
solved in 1 ml 0.05 M sodium acetate pH 4.5, sodium periodate
was added to a final concentration of 0.01 M and the mixture
was incubated overnight at 4°C.
In each of the above cases the solution containing the
modified THP was desalted and buffer exchanged in a Centricon
10 microconcentrator (Amicon Ltd, Gloucester, UK) and re-
suspended to a final concentration of 1 mg/mI in PBS.
Neutrophil plasma membranes
Human PMN (30 x 10) were subjected to sonication (14 pm
peak to peak in a 150 W ultrasonic disintegrator, MSE Ltd,
Crawley, UK) until >90% were ruptured as assessed by phase
contrast microscopy. Plasma membrane-rich fractions were
prepared from the disrupted cell suspension by differential
centrifugation as described by Klempner et al [15]. This method
yielded fractions containing nuclear (1,500 g pellet), granular
(20,000 g pellet), plasma membrane (100,000 g pellet) and
cytosolic (final supernatant) material. Activity of the marker
enzyme 5' nucleotidase was confined to the 100,000 g pellet
indicating that this fraction was enriched with plasma mem-
branes. The identity of the other fractions was confirmed by
assaying for DNA (nuclear fraction) [16], myeloperoxidase
(granular/lysosomal fraction) [17] and lactate dehydrogenase
(cytosolic fraction) [18].
Binding assays
(a) Binding of 1251-labeled THP to intact PMN. All assays
were performed at 4°C using Krebs Ringer phosphate, pH 7.4
containing 0.54 m calcium chloride, 1.2 m magnesium sul-
phate, Il mts D-glucose and 0.02% (wt/vol) sodium azide
(KRPG) as the incubation buffer. Two times 106 PMN were
incubated with varying quantities of 1251-THP in a total reaction
volume of 0.5 ml. Cell associated and free radioactivity were
separated by layering 150 d aliquots of reaction mixture (in
triplicate) on to 200 d of ice cold silicone-mineral oil (4 parts
silicone DCS5O: I part mineral oil, final density 1.02 g/liter) and
spinning at 11,000 g in a Beckman microfuge B (Beckman Ltd,
High Wycombe, UK) to pellet the cells below the oil layer. The
tubes were sliced through the center of the oil layer and the
supernatant and pellet assayed separately for radioactivity.
Counts obtained from control incubations that contained radi-
oligand but no PMN were subtracted from all test results.
Typically these control incubations amounted to 2% and 10% of
total bound at low and high ligand concentration, respectively.
Binding data were analyzed using the nonlinear regression
program LIGAND [19].
The rate of association of 1251-THP and human PMN with
time was measured by incubating 2 x 106 PMN with 250 ng
'251-THP at 4°C and terminating the reaction at selected times
as described above.
For dissociation studies 2 x 106 PMN and 250 ng '251-THP in
a 125 d volume of KRPG-azide were placed over 200 .d of ice
cold oil in a 400 1.d microcentrifuge tube and incubated at 4°C
until steady state binding had been achieved (as determined
from association studies). A 500-fold excess of unlabeled solu-
ble THP was then added for accurately measured time periods
and the reaction stopped as before.
(b) Binding of '251-labe!ed THP to immobilized PMN mem-
branes. Aliquots of membrane protein (1 g) were dotted onto
nitrocellulose filters and allowed to dry at room temperature.
The filters were then cut into 0.9 x 0.9 cm squares with the
membrane protein at the centre and placed into 24-well tissue
culture plates. Nonspecific binding sites were blocked for 45
minutes at room temperature by the addition of 500 /.Li per well
Tris buffered saline (0.05 M Tris-HC1, 0.2 M NaCl, pH 7.4-TBS)
containing 5% (wt/vol) skimmed milk or 2% (wt/vol) BSA. The
blocking solution was aspirated and the filters washed with 3 X
500 ,td TBS before incubation with 250 ng '251-THP for three
hours at 4°C in the presence or absence of unlabeled competi-
tors. Following aspiration of the binding solution the filters
were washed extensively with TBS containing 0.05% (vol/vol)
Tween 80, removed and dried. Binding was assessed by expos-
ing the nitrocellulose filters to Kodak X Omat AR film at —70°C.
Results
Binding of '25I-1abe1ed THP to intact human PMN
Saturation binding studies. '251-labeled monomeric THP
bound to human PMN at 4°C in a concentration dependent
manner (Fig. 1A). The experimentally-derived total binding
component increased linearly at concentrations >300 ng 125J
THP/2 x 10 PMN. Inclusion of unlabeled THP in the binding
assay resulted in a dose dependent displacement of cell associ-
ated radioactivity (data not shown). Data from these experi-
ments was highly variable, however, and required at least a
1000-fold excess of unlabeled THP to achieve maximal dis-
placement. In view of this constraint on the use of excess cold
THP, we opted to extrapolate the linear slope of the total
binding curve back to zero to generate a non-specific binding
component. Subtraction of this from total binding produced a
specific binding curve which indicated that 400 to 600 ng 1251
THP/2 X 10 PMN was sufficient to achieve saturable binding.
When total binding data were subjected to analysis using the
nonlinear curve fitting program LIGAND [19] the data closely
fitted a one site model following subtraction of computer
generated nonspecific binding. Consideration of additional
binding sites did not improve the fit. Scatchard transformation
of the data yielded a linear plot typical of a single class of
receptors (Fig. 1B). Analysis of data from six experiments with
cells from different donors revealed a mean receptor density of
26,218 12,598 sites per cell and a dissociation constant (KD)
of 4.2 2.2 x iO M (results are mean so).
Time dependency studies. Experiments were performed
which measured the association and dissociation of 1251 THP
with time. In addition to providing information on THP-PMN
binding kinetics these studies enabled the experimental deriva-
tion of KD which could be compared to that generated by
Scatchard analysis of equilibrium binding. Figure 2A shows that
binding of 1251 THP to human PMN was time dependent and
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Fig. 1. Binding of'251-labeled THP to intact human PMN at 4°C as a
function of concentration. A. 2 x 106 PMN were incubated with varying
quantities of '251-THP for 15 minutes at 4°C as described in Methods.
The linear slope of the experimentally derived total binding (•)was
extrapolated back to zero to yield a nonspecific binding component (0).
Specific binding (A) was then estimated by subtraction of nonspecific
from total binding. B. Scatchard analysis of total binding data corrected
for nonspecific binding by the LIGAND program.
reached steady state by 15 minutes. Semi-logarithmic transfor-
mation of association data yielded a linear plot (Fig. 2B), the
slope of which generated an experimentally-observed associa-
tion rate constant (KObS) of 0. 139 0.02 min (N = 3). The use
of a half-maximal saturating concentration of 1251 THP in time
dependency studies made it possible to demonstrate dissocia-
tion with workable concentrations of excess unlabeled THP.
Addition of a 500-fold excess of unlabeled THP to a binding
mixture at equilibrium resulted in a rapid dissociation of bound
radioactivity that reached steady state within one minute (Fig.
3A). The rate constant for dissociation (K2) calculated from
semi-logarithmic transformed data (Fig. 3B) was 2.06 0.46 X
10—2 min (N = 3). The association constant K1 was deter-
mined from KObS and K2 as previously described [20], and the
ratio of K2 to K1 then yielded a value of 0.9 0.05 X i0 M (N
= 3) for the kinetically-derived dissociation constant KD.
Binding constants obtained from kinetic analysis are summa-
rized in Table 1.
Binding of 1251-labeled THP to immobilized PMN plasma
membranes
When equivalent amounts of protein from each fraction of the
homogenized PMN suspension were immobilized onto nitrocel-
lulose filters and incubated with '251-THP, the major binding
SPECIFIC was to protein of the plasma membrane fraction (Fig. 4). This
binding was dose dependent with respect to both radioligand
and membrane protein (data not shown), while inclusion of
unlabeled THP in the incubation mixture resulted in the dis-
placement of binding (Fig. 5, lane 1).
The solid phase binding assay was also used to investigate the
effect of chemical modification of THP on the ability of the
glycoprotein to bind to PMN. Monomeric THP was subjected
to reduction and alkylation which irreversibly breaks internal
disulphide bridges and results in unfolding of the protein. The
exposed carbohydrate residues of monomeric THP were also
modified by periodate oxidation which cleaves the alkyl chain
of sialic acid between vicinal hydroxyls to generate aldehyde
groups. Both reductive alkylation and periodate oxidation abol-
ished the ability of unlabeled THP to competitively bind to
PMN membranes (Fig. 5, lanes 2 and 3). This would suggest
that THP requires both an unmodified tertiary protein structure
and intact carbohydrate residues to bind to human PMN.
The role of the carbohydrate moiety of THP in cell surface
recognition was further investigated by assessing the potential
of defined monosaccharides to inhibit binding of 1251-THP to
immobilized PMN membranes. Sugars which have been shown
to be present in the carbohydrate portion of THP were pre-
incubated with PMN membranes prior to the addition of 125J
THP. Figure 6 shows that only sialic acid gave appreciable
displacement of binding over the concentration range studied.
Some displacement was also observed with the highest concen-
trations of N-acetyl hexosamines (50 to 100 mM). It is likely that
this latter phenomenon reflects trace contamination of the
N-acetyl sugars with sialic acid, since inclusion of these sugars
in a periodate thiobarbituric acid assay [211 indicated that
N-acetyl galactosamine and N-acetyl glucosamine contained
5.2% and 3.8% sialic acid, respectively. All solid phase binding
experiments were repeated three times. The figures shown are
from single representative experiments.
Discussion
The present study has further characterized the previously
described THP-PMN interaction by examining the binding of
'251-labeled monomeric THP to human PMN at 4°C. Binding of
'251THP to intact, viable PMN was saturable, time dependent
and reversible. Scatchard analysis of equilibrium binding data
generated linear plots indicating the presence of a single class of
receptors with a density of 26,218/cell and a KD of 4.2 x l0—
M.
Scatchard plots were derived from total binding data using
the nonlinear regression program LIGAND. This approach
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Fig. 2. Association kinetics of '251-labeled
THP binding to intact human PMN at 4°C. A.
250 ng of '251-THP was incubated with 2 x
106 PMN for the times indicated, and the
reaction terminated as described in Methods.
B. Semi-logarithmic transformation of
association data plotted as In (Bq/Beq — B)
vs. time, where Beq is the binding at steady
state and B is the binding at the times
12 indicated. The results shown are the mean
from three separate experiments using cells
from different donors.
Fig. 3. Dissociation kinetics of '251-labeled
THP binding to intact human PMN at 4°C. A.
Time course for dissociation of cell associated
radioactivity following the addition of 125 sg
of unlabeled THP to a binding mixture of 250
ng '251-THP and 2 x 106 PMN at equilibrium.
B. Semi-logarithmic transformation of
dissociation data plotted as In (B/B0) vs. time,
where Bc, is the binding at steady state and B
0 20 40 60 80 0 10 20 30 the binding at the times indicated. The results
shown are the mean from three separate
Time, seconds experiments using cells from different donors.
Table 1. Kinetic parameters of 125j THP binding to human PMN
KOb K2
K1M'min'
Kinetically
derived
K0Mmin'
0.139 0.02 2.06
x
0.4610 22.5 3.7x 10 0.9 0.05x l0
Where K0,, and K2 were determined from the slopes of semi-
logarithmic plots of association and dissociation data, respectively. The
association rate constant K1 was determined from the equation
(KOb. — K2)
[L]
where [L] is the radioligand concentration. The kinetically-derived
dissociation constant KD was then calculated from the ratio of I(2/K1.
The results are the mean su for three separate experiments using cells
from different donors.
avoided the need to use an excess of unlabeled THP to
determine nonspecific binding. While dose dependent displace-
ment of labeled by unlabeled material is the usual method of
estimating specific binding, it is recognized that such a method
is prone to artifactual conclusions. It frequently results in the
generation of erroneous curvilinear Scatchard plots with the
resultant overestimation of receptor number and underestima-
tion of binding affinity [22]. Furthermore, the fact that a large
excess of unlabeled THP is required to achieve maximal dis-
placement of labeled ligand is likely to render specific binding
data generated by this method unreliable, given that high
concentrations of soluble THP promote autoaggregation of the
glycoprotein [23].
Kinetic studies showed that both the binding of '251-THP to
intact PMN and the dissociation of the radiolabeled protein
from PMN following the addition of excess unlabeled THP to a
binding mixture at equilibrium were time dependent. Semi-
logarithmic transformation of association and dissociation data
enabled a kinetically derived KD of 0.9 X i0 M to be
calculated, a value comparable to that generated from Scatch-
ard analysis of equilibrium binding data. Thus similar values for
the dissociation constant of THP binding receptors could be
obtained by two separate experimental approaches.
In addition to binding experiments using intact PMN, the
present study also employed a solid phase dot blot assay to
investigate the specificity of the THP-PMN interaction. Initial
studies showed that when equivalent amounts of protein from
nuclear, granular, cytosolic and plasma membrane fractions
were immobilized onto nitrocellulose and incubated with 125j
THP, significant binding was only observed to the plasma
membrane fraction, providing further evidence for a cell surface
recognition mechanism. The ability of THP to bind to PMN
plasma membranes is apparently lost upon disruption of the
tertiary protein structure of the THP monomer, as evidenced by
the fact that reductive alkylation abolished the ability of unla-
beled THP to displace binding of '251-THP in the dot blot assay.
2 k00 = 0.139 mm
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Fig. 4. Binding of '251-labeled THP to
fractions prepared by differential
centrifugation of a sonicated PMN
suspension. One microgram aliquots of
protein from nuclear (1,500 g pellet), granular
(20,000 g pellet), plasma membrane (100,000 g
pellet) and cytosolic (100,000 g supernatant)
fractions were immobilized onto nitrocellulose
filters and incubated with doubling dilutions
(18 to 600 nglwell) of I2sITHP for three hours
at 4°C as described in the Methods.
Unlabeled THP, pg/we/I
Receptor mediated recognition by phagocytes can occur
through a variety of carbohydrate dependent mechanisms.
Activation of human PMN by zymosan is related to both its
major carbohydrate components, mannan and glucan [24]. In
addition the receptor mediated uptake of mannose/N-acetyl
glucosamine terminated glycoproteins by macrophages has
been described [25], while studies by Savill et al [261 have
indicated that the recognition and phagocytosis of senescent
neutrophils by macrophage vitronectin receptors can be specif-
ically inhibited by amino sugars. The carbohydrate moiety of
THP which accounts for 30% of the glycoprotein by weight has
been shown to contain mannose, fucose, glucose, galactose,
N-acetyl glucosamine/galactosamine and neuraminic (sialic)
acid [27]. The majority of the oligosaccharides expressed on
THP consist of complex sialylated polybranched chains bound
to a triple mannose core [28]. These chains exhibit significant
heterogeneity with several potential sites for sugar-mediated
receptor recognition.
The results of the present study suggest a role for the terminal
Fig. 5. Ability of unlabeled THP to inhibit
binding of '251-labeled THP to immobilized
PMN plasma membranes. Two hundred and
fifty nanograms of '251-THP was incubated
with nitrocellulose filters containing 1 g
aliquots of immobilized PMN plasma
membrane protein for three hours at 4°C in
the presence of unmodified unlabeled THP
(lane I), unlabeled THP treated with 0.01 M
sodium penodate in 0.05 M sodium acetate,
pH 4.5 for 16 hours at 4°C (lane 2) and
unlabeled THP reduced with 0.01 M
dithiothreitol in 0.05 M Tris-HCI pH 8.0 for 16
hours and alkylated with 0.01 M
iodoacetamide for two hours at room
temperature (lane 3). Filters were washed and
binding assessed as described in the Methods.
sugar residues of THP in the binding of the glycoprotein to
PMN. Chemical modification of exposed sugar residues by
periodate oxidation abolished the ability of unlabeled THP to
inhibit binding in the solid phase assay. Furthermore, specific
inhibition studies with defined monosaccharides demonstrated
that sialic acid was able to dose dependently displace radioli-
gand binding. The sialic acid-dependent binding of THP to
PMN is an intriguing observation, particularly since previous
research has demonstrated that the capability of certain partic-
ulate ligands to activate human phagocytes is enhanced by the
removal of sialic acid residues [29]. Whether the demonstration
of sialic acid-dependent binding indicates that THP exhibits a
lectin type interaction with human PMN remains to be eluci-
dated, although the literature does contain references to the fact
that the carbohydrate moiety of THP is involved in lectin
binding reactions. In particular, Serafini-Cessi et al [30] dem-
onstrated that THP competitively inhibited leukoagglutinin-
induced lymphocyte transformation via a N-acetyl galac-
tosamine-mediated mechanism. In addition, several studies
250 125 62.5 31.2 15.6 0
1
2
3
0S
S.
•5
.
. • .
• • • •
C
428 Thomas et al: Tamm Horsfall protein receptor on neutrophils
Concentration of neutral sugar, m Acknowledgments
This work was supported by a Medical Research Council Project
100 50 25 12.5 6.25 0 grant to DBLT. We thank Cheryl Patterson for secretarial assistance.
NANA
Fig. 6. Binding of 1251-labeled THF to immobilized PMN membranes
in the presence of defined monosaccharides. One microgram of mem-
brane protein was immobilized onto nitrocellulose filters and non-
specific binding sites blocked with TBS containing 2% (wt/vol) BSA.
Filters were incubated with 200 [4 TBS containing glucose (Glue),
fucose (Fuc), galactose (Gal), mannose (Man), N-acetyl galactosamine
(NAGaI), N-acetyl glucosamine (NAGIuc) and N-acetyl neuraminic
(sialic) acid (NANA) at the concentrations indicated for 30 minutes at
4°C. Then 250 ng (50 [4) of '251-THP was added and the incubation
continued for three hours at 4°C. Filters were washed and binding
assessed as described in the Methods.
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